Cargando…

Cordycepin Accelerates Osteoblast Mineralization and Attenuates Osteoclast Differentiation In Vitro

Bone homeostasis destruction is triggered by the uncontrolled activity of osteoblasts and osteoclasts. Targeting both the regulation of bone formation and resorption is a promising strategy for treating bone disorders. Cordycepin is a major component of Chinese caterpillar fungus Cordyceps militaris...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Su-Bin, Kim, Hye-Jin, Kang, Hae-Mi, Park, Bong-Soo, Lee, Ji-Hye, Kim, In-Ryoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206560/
https://www.ncbi.nlm.nih.gov/pubmed/30410556
http://dx.doi.org/10.1155/2018/5892957
_version_ 1783366371507175424
author Yu, Su-Bin
Kim, Hye-Jin
Kang, Hae-Mi
Park, Bong-Soo
Lee, Ji-Hye
Kim, In-Ryoung
author_facet Yu, Su-Bin
Kim, Hye-Jin
Kang, Hae-Mi
Park, Bong-Soo
Lee, Ji-Hye
Kim, In-Ryoung
author_sort Yu, Su-Bin
collection PubMed
description Bone homeostasis destruction is triggered by the uncontrolled activity of osteoblasts and osteoclasts. Targeting both the regulation of bone formation and resorption is a promising strategy for treating bone disorders. Cordycepin is a major component of Chinese caterpillar fungus Cordyceps militaris. It exerts a variety of biological actions in various cells and animal models. However, its function on bone metabolism remains unclear. In the present study, we discovered a dual-action function of cordycepin in murine MC3T3-E1 and RAW264.7 cells. MC3T3-E1 cells were cultured in an osteogenic medium in the presence of 1 μM cordycepin for up two weeks. Cordycepin was used for effects of osteoblast and osteoclast differentiation. Cell viability was measured using the MTT assay. Osteoblast differentiation was confirmed by alizarin red staining, ALP activity, western blot, and real-time PCR. Osteoclast differentiation and autophagic activity were confirmed via TRAP staining, pit formation assay, confocal microscopy, western blot, and real-time PCR. Cordycepin promoted osteoblast differentiation, matrix mineralization, and induction of osteoblast markers via BMP2/Runx2/Osterix pathway. On the other hand, RAW264.7 cells were differentiated into osteoclast by RANKL treatment for 72 h. 1 μM cordycepin significantly inhibited RANKL-induced osteoclast formation and resorption activity through disturbing the actin ring-formatted sealing zone and activating cathepsin K and MMP9. These findings indicate that cordycepin might be an innovative dual-action therapeutic agent for bone disease caused by an imbalance of osteoblasts and osteoclasts.
format Online
Article
Text
id pubmed-6206560
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-62065602018-11-08 Cordycepin Accelerates Osteoblast Mineralization and Attenuates Osteoclast Differentiation In Vitro Yu, Su-Bin Kim, Hye-Jin Kang, Hae-Mi Park, Bong-Soo Lee, Ji-Hye Kim, In-Ryoung Evid Based Complement Alternat Med Research Article Bone homeostasis destruction is triggered by the uncontrolled activity of osteoblasts and osteoclasts. Targeting both the regulation of bone formation and resorption is a promising strategy for treating bone disorders. Cordycepin is a major component of Chinese caterpillar fungus Cordyceps militaris. It exerts a variety of biological actions in various cells and animal models. However, its function on bone metabolism remains unclear. In the present study, we discovered a dual-action function of cordycepin in murine MC3T3-E1 and RAW264.7 cells. MC3T3-E1 cells were cultured in an osteogenic medium in the presence of 1 μM cordycepin for up two weeks. Cordycepin was used for effects of osteoblast and osteoclast differentiation. Cell viability was measured using the MTT assay. Osteoblast differentiation was confirmed by alizarin red staining, ALP activity, western blot, and real-time PCR. Osteoclast differentiation and autophagic activity were confirmed via TRAP staining, pit formation assay, confocal microscopy, western blot, and real-time PCR. Cordycepin promoted osteoblast differentiation, matrix mineralization, and induction of osteoblast markers via BMP2/Runx2/Osterix pathway. On the other hand, RAW264.7 cells were differentiated into osteoclast by RANKL treatment for 72 h. 1 μM cordycepin significantly inhibited RANKL-induced osteoclast formation and resorption activity through disturbing the actin ring-formatted sealing zone and activating cathepsin K and MMP9. These findings indicate that cordycepin might be an innovative dual-action therapeutic agent for bone disease caused by an imbalance of osteoblasts and osteoclasts. Hindawi 2018-10-16 /pmc/articles/PMC6206560/ /pubmed/30410556 http://dx.doi.org/10.1155/2018/5892957 Text en Copyright © 2018 Su-Bin Yu et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yu, Su-Bin
Kim, Hye-Jin
Kang, Hae-Mi
Park, Bong-Soo
Lee, Ji-Hye
Kim, In-Ryoung
Cordycepin Accelerates Osteoblast Mineralization and Attenuates Osteoclast Differentiation In Vitro
title Cordycepin Accelerates Osteoblast Mineralization and Attenuates Osteoclast Differentiation In Vitro
title_full Cordycepin Accelerates Osteoblast Mineralization and Attenuates Osteoclast Differentiation In Vitro
title_fullStr Cordycepin Accelerates Osteoblast Mineralization and Attenuates Osteoclast Differentiation In Vitro
title_full_unstemmed Cordycepin Accelerates Osteoblast Mineralization and Attenuates Osteoclast Differentiation In Vitro
title_short Cordycepin Accelerates Osteoblast Mineralization and Attenuates Osteoclast Differentiation In Vitro
title_sort cordycepin accelerates osteoblast mineralization and attenuates osteoclast differentiation in vitro
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206560/
https://www.ncbi.nlm.nih.gov/pubmed/30410556
http://dx.doi.org/10.1155/2018/5892957
work_keys_str_mv AT yusubin cordycepinacceleratesosteoblastmineralizationandattenuatesosteoclastdifferentiationinvitro
AT kimhyejin cordycepinacceleratesosteoblastmineralizationandattenuatesosteoclastdifferentiationinvitro
AT kanghaemi cordycepinacceleratesosteoblastmineralizationandattenuatesosteoclastdifferentiationinvitro
AT parkbongsoo cordycepinacceleratesosteoblastmineralizationandattenuatesosteoclastdifferentiationinvitro
AT leejihye cordycepinacceleratesosteoblastmineralizationandattenuatesosteoclastdifferentiationinvitro
AT kiminryoung cordycepinacceleratesosteoblastmineralizationandattenuatesosteoclastdifferentiationinvitro